Skip to content

FARMASO: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FARMASO

BE 0866.899.985
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€22,982
2024 · €20,118+€2,864
Equity
€279,254
2024 · €256,272+€22,982
Cash
€142,172
2024 · €111,038+€31,134
Balance sheet total
€293,804
2024 · €264,207+€29,598

Largest movements

2024 to 2025
Assets
  • Cash +€31,134

    up €31,134 (+28.0%), from €111,038 to €142,172

    mainly Net result for the year (+€22,982) and Investment in fixed assets (net) (+€14,167)

  • Receivables within one year +€23,355

    up €23,355 (+269.7%), from €8,659 to €32,014

    of which Trade receivables: +€13,792

  • Financial fixed assets -€14,167

    down €14,167 (-16.7%), from €85,000 to €70,833

  • Receivables after one year -€10,000

    down €10,000 (-17.2%), from €58,000 to €48,000

Equity and liabilities
  • Reserves +€22,982

    up €22,982 (+9.7%), from €237,672 to €260,654

  • Tax, wage and social debts +€6,212

    up €6,212 (+84.7%), from €7,334 to €13,546

Income statement
  • Gross operating margin +€8,755

    up €8,755 (+29.6%), from €29,587 to €38,342

  • Financial charges +€3,780

    up €3,780 (+2882.2%), from €131 to €3,911

  • Taxes +€2,404

    up €2,404 (+30.3%), from €7,921 to €10,325

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €20,118
Gross operating margin +€8,755
Depreciation -€0
Other operating charges -€12
Financial income +€304
Financial charges -€3,780
Taxes -€2,404
Result 2025 €22,982

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€16,967
Investment +€14,167
Financing €0
Cash 2024 €111,038
Net result for the year +€22,982
Depreciation +€1,029
Receivables after one year +€10,000
Receivables within one year -€23,355
Deferred charges and accrued income -€304
Trade debts +€404
Tax, wage and social debts +€6,212
Investment in fixed assets (net) +€14,167
Cash 2025 €142,172
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €264,207 €293,804 +€29,598 +11.2%
Fixed assets 21/28 €86,509 €71,314 -€15,196 -17.6%
Tangible fixed assets 22/27 €1,509 €480 -€1,029 -68.2%
Furniture and vehicles 24 €1,509 €480 -€1,029 -68.2%
Financial fixed assets 28 €85,000 €70,833 -€14,167 -16.7%
Current assets 29/58 €177,697 €222,490 +€44,793 +25.2%
Amounts receivable after more than one year 29 €58,000 €48,000 -€10,000 -17.2%
Other amounts receivable 291 €58,000 €48,000 -€10,000 -17.2%
Amounts receivable within one year 40/41 €8,659 €32,014 +€23,355 +269.7%
Trade receivables 40 €8,198 €21,990 +€13,792 +168.2%
Other amounts receivable 41 €461 €10,024 +€9,563 +2073.6%
Cash at bank and in hand 54/58 €111,038 €142,172 +€31,134 +28.0%
Deferred charges and accrued income 490/1 - €304 +€304
Total equity and liabilities 10/49 €264,207 €293,804 +€29,598 +11.2%
Equity 10/15 €256,272 €279,254 +€22,982 +9.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €237,672 €260,654 +€22,982 +9.7%
Distributable reserves 133 €237,672 €260,654 +€22,982 +9.7%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €7,935 €14,550 +€6,616 +83.4%
Amounts payable within one year 42/48 €7,935 €14,550 +€6,616 +83.4%
Trade debts 44 €601 €1,005 +€404 +67.2%
Suppliers 440/4 €601 €1,005 +€404 +67.2%
Taxes, remuneration and social security 45 €7,334 €13,546 +€6,212 +84.7%
Taxes 450/3 €7,334 €13,546 +€6,212 +84.7%
Other amounts payable 47/48 €0 - =
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,029 €1,029 +€0 0.0%
Other operating charges 640/8 €387 €400 +€12 +3.2%
Gross operating margin 9900 €29,587 €38,342 +€8,755 +29.6%
Operating profit (loss) 9901 €28,170 €36,913 +€8,743 +31.0%
Financial income 75/76B - €304 +€304
Recurring financial income 75 - €304 +€304
Financial charges 65/66B €131 €3,911 +€3,780 +2882.2%
Recurring financial charges 65 €131 €3,911 +€3,780 +2882.2%
Profit (loss) for the period before taxes 9903 €28,039 €33,307 +€5,268 +18.8%
Income taxes 67/77 €7,921 €10,325 +€2,404 +30.3%
Profit (loss) for the period 9904 €20,118 €22,982 +€2,864 +14.2%
Profit (loss) for the period to be appropriated 9905 €20,118 €22,982 +€2,864 +14.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.